SecBot SecBot

WST

WEST PHARMACEUTICAL SERVICES INC
NYSE· Surgical & Medical Instruments & Apparatus· Inc. PA· CIK 0000105770 Biotech & Drug Discovery
$417.80 +1.38 (+0.33%)
Nov 16 4:00 PM ET · prev $416.42
Market cap
$28.7B
Large cap
Consensus
Buy
95% Buy or better · 21 analysts
Median target
$480.00
+15% · range $340.00–500.00
1 year
+59.2%
from $262.41 · Nov 17
30 days
+8.8%
from $383.91
52-week range
$230.95–417.80
at the high
Avg volume 20D
775.0K
shares / day
Short interest
1.81M
≈2.6% of shares · −10.2%
Days to cover
2.3
at average volume
Insider net
−$6.6M
0 buyers · 2 sellers · since Mar 1
New fund stakes
3
Q2 2026 13F · 1 exit
Filing reports
17
analyzed by SecBot
SecBot read BULLISH 5 reports · 90 days
Balance 0 bearish · 2 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 4/5

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders sold $6.6M.

  • InstitutionsBULLISH

    Q2 2026: 60 added (3 new), 35 trimmed or exited. Largest new: Boston Trust Walden $29.2M, Capitolis Liquid Global Markets $12.8M.

  • AnalystsBULLISH

    20 of 21 rate it Buy or better. Median target $480.00 (+15%).

  • EstimatesFLAT

    Current-quarter EPS estimate $2.270 → $2.284 over 90 days. 6 up, 2 down in 30 days.

  • Short sellersSTEADY

    Short interest −10.2% to 1.81M shares. 2.3 days to cover, ≈2.6% of shares.

  • TrendUPTREND

    9% above its 50-day average. New closing high $417.80 on Nov 16.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 28.

Who's buying

13F· Q2 2026
3
new positions
1
exit
$53.0M
in new stakes
FundMoveSharesValue
FMR LLCDOUBLED3,574,816$1.3B
JACOBS LEVY EQUITY MANAGEMENT, INCTRIM507,786$182.3M
STATE FARM MUTUAL AUTOMOBILE INSURANCE COADD495,334$177.8M
APG Asset Management N.V.TRIM560,582$176.0M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCDOUBLED417,309$149.8M
AmundiTRIM385,311$138.3M
UBS Group AGADD374,361$134.4M
Quantinno Capital Management LPADD308,116$110.6M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

21 analysts
Buy 95% rate it Buy or better
Strong Buy7Buy13Hold1Sell0Strong Sell0
12-month targets · 15 analysts

Price is inside the target range. Median implies +15%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Oct 30, 2026Citigroup
MAINTAIN
MAINTAINBuy
Oct 30, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Oct 30, 2026Barclays
MAINTAIN
MAINTAINOverweight
Oct 30, 2026Evercore ISI Group
MAINTAIN
MAINTAINOutperform
Oct 13, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Oct 7, 2026Barclays
MAINTAIN
MAINTAINOverweight
Congressional trades
WST trades disclosed by members of Congress, with disclosure delay.
1 members · 0 buys / 1 sells
DateMemberType AmountDisclosed
May 27, 2026 Ro KhannaDHouse Spouse account · West Pharmaceutical Services Inc SELL $1K–$15K Jun 9, 2026 +13d

Insider ledger

Form 4
$0
bought · 0 insiders
$6.6M
sold · 2 insiders
DateInsiderTypeValue
Sep 30, 2026
HAUGEN JANET BRUTSCHEA
Director
Sep 30, 2026
AWARD$16.3K
Sep 15, 2026
Favorite Annette F
Sr. VP & Chief HR Officer
Sep 15, 2026
EXERCISE$226.3K
Sep 15, 2026
Favorite Annette F
Sr. VP & Chief HR Officer
Sep 15, 2026
SELL$921.3K
Sep 14, 2026
Favorite Annette F
Sr. VP & Chief HR Officer
Sep 14, 2026
EXERCISE$224.1K
Sep 14, 2026
Favorite Annette F
Sr. VP & Chief HR Officer
Sep 14, 2026
SELL$887.5K
Sep 11, 2026
Favorite Annette F
Sr. VP & Chief HR Officer
Sep 11, 2026
SELL$862.5K
Sep 11, 2026
Favorite Annette F
Sr. VP & Chief HR Officer
Sep 11, 2026
EXERCISE$224.1K
Sep 8, 2026
Lagarde Michel
President and CEO
Sep 8, 2026
AWARD13,879 sh

Earnings setup

Estimates
$2.28
EPS estimate, this quarter
+1%
estimate change, 90 days
6↑ 2↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$2.28$2.23–$2.32+0.5%$825.2M
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

8 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
1,807,517
shares short
-10.2%
vs prior settlement
2.3
days to cover
≈2.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 5, 2026 SEC
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 5,962,737.88 shares of West…
SC 13G/A · Impact 2/10
Nov 4, 2026 Other
West to Participate in Upcoming Investor Conference
EXTON, Pa., Nov. 4, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global le
Oct 29, 2026 SEC
West Pharmaceutical reported Q3 2026 net sales of $874.5M (+8.7% reported, +11.9% organic) and adjusted-diluted EPS of…
8-K · Impact 6/10
Oct 29, 2026 SEC
West Pharmaceutical Services reported Q3 2026 adjusted-diluted EPS of $2.66, beating the $2.20 consensus by 20.9%, and…
PRESS-RELEASE · Impact 6/10
Sep 30, 2026 Insider
HAUGEN JANET BRUTSCHEA was granted 44 shares
Director @ $370.76 ($16.3K)
Sep 15, 2026 Insider
Favorite Annette F acquired via exercise 2,524 shares
Sr. VP & Chief HR Officer @ $89.64 ($226.3K)
Sep 15, 2026 Insider
Favorite Annette F sold 2,524 shares
Sr. VP & Chief HR Officer @ $365.00 ($921.3K)
Jun 30, 2026 Inst.
FMR LLC · DOUBLED
3,574,816 shares ($1.3B)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 4, 2026
Press release
West to Participate in Upcoming Investor Conference
EXTON, Pa., Nov. 4, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug…
Oct 29, 2026
Earnings
West Reports Third-Quarter 2026 Results
Raising Full-Year Net Sales and Adjusted-Diluted EPS guidance EXTON, Pa., Oct. 29, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE…
Oct 29, 2026
Earnings result
WST Q3 2026 Earnings: EPS $2.66 (+20.2% vs est)
Oct 21, 2026
Earnings date
WST Q3 2026 Earnings Before Market Open, 2026-10-21
Oct 5, 2026
Press release
West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide
EXTON, Pa., Oct. 5, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug…

SecBot reports

17 filings · 5 bullish · 1 bearish · 11 neutral
All WST filing & press-release reports (17)